跳至主要内容
临床试验/KCT0004597
KCT0004597进行中(未招募)未知

A prospective study on efficacy and safety of insulin degludec/insulin aspart compared to insulin glargine and the relation with glycemic variability in patients with type 2 diabetes

Seoul National University Hospital0 个研究点目标入组 55 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. patients in the outpatient clinic of SNUH, with type 2 diabetes
  • 2. age > 19 years
  • 3. under treatment with once-daily basal insulin (< 1 IU/kg) for more than 4 months
  • 4. HbA1c >= 7% and <=10%
  • 5. marked postprandial hyperglycemia estimated by FPG and HbA1c
  • 6. No change in blood sugar lowering medication taken during the study period

排除标准

  • 1. Type 1 diabetes
  • 2. When using insulin other than Insulin glargine U100, Insulin glargine U300, and insulin degludec
  • 3. pregnancy, breast feeding
  • 4. major CVD events or malignancy with the past 6 months
  • 5. uncontrolled hypertension
  • 6. any medications or serious diseases known to significantly affect weight or glucose metabolism
  • 7. irregular diet

研究者

相似试验